Skip to search formSkip to main contentSkip to account menu

stage III melanoma

Known as: Stage III Skin Melanoma AJCC v6, stage III cutaneous melanoma, Stage III Melanoma of the Skin AJCC v6 
The tumor may be any thickness, with or without ulceration (a break in the skin), and one or more of the following is true: (1) cancer has spread to… 
National Institutes of Health

Related topics

Related topics

9 relations
Body tissueIntegumentary systemMelanoma CellNeoplastic Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial.
Highly Cited
2018
Highly Cited
2018
The new era of adjuvant therapies for melanoma
New treatment options for patients with resected stage III melanoma have been established with the publication of the results of… 
Highly Cited
2014
Highly Cited
2014
Ipilimumab versus placebo after complete resection of stage III melanoma: Initial efficacy and safety results from the EORTC 18071 phase III trial.
LBA9008 Background: Ipilimumab (Ipi), a fully human monoclonal antibody that blocks cytotoxic T-lymphocyte antigen-4 to augment… 
Review
2011
Review
2011
Sarcopenia as a Prognostic Factor among Patients with Stage III Melanoma
BackgroundSeveral hypotheses proposed to explain the worse prognosis for older melanoma patients include different tumor biology… 
Highly Cited
2008
Highly Cited
2008
Semi-automated volumetric analysis of lymph node metastases in patients with malignant melanoma stage III/IV-A feasibility study
Therapy monitoring in oncological patient care requires accurate and reliable imaging and post-processing methods. RECIST… 
Highly Cited
2005
Highly Cited
2005
Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.
PURPOSE Circulating tumor cells (CTCs) in blood may be important in assessing tumor progression and treatment response. We… 
Highly Cited
2004
Highly Cited
2004
Contemporary surgical treatment of advanced-stage melanoma.
HYPOTHESIS The clinical treatment of patients with stage IV melanoma according to criteria of the American Joint Committee on… 
Highly Cited
2002
Highly Cited
2002
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients
Abstract. Adoptive therapy for cancer using tumor-infiltrating lymphocytes (TIL) has mainly been investigated in cancer patients… 
Highly Cited
1998
Highly Cited
1998
A 15-Year Follow-up of AJCC Stage III Malignant Melanoma Patients Treated Postsurgically with Newcastle Disease Virus (NDV) Oncolysate and Determination of Alterations in the CD8 T Cell Repertoire
BackgroundThe development of effective adjuvant therapies for the treatment of high-risk melanoma patients is critical for the… 
Highly Cited
1993
Highly Cited
1993
Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)